WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996009299) DRUGS TO IMPROVED SYNAPTIC TRANSMISSION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/009299    International Application No.:    PCT/US1995/010454
Publication Date: 28.03.1996 International Filing Date: 16.08.1995
Chapter 2 Demand Filed:    04.03.1996    
IPC:
C07C 69/732 (2006.01), C07D 225/04 (2006.01), C07D 225/06 (2006.01), C07D 313/00 (2006.01)
Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US/US]; 22nd floor, 300 Lakeside Drive, Oakland, CA 94612-3550 (US)
Inventors: SUMIKAWA, Katumi; (US).
ITO, Ken-Ichi; (JP).
McGAUGH, James, L.; (US)
Agent: BERLINER, Robert; Robbins, Berliner & Carson, 5th floor, 201 N. Figueroa Street, Los Angeles, CA 90012-2628 (US)
Priority Data:
08/309,871 20.09.1994 US
Title (EN) DRUGS TO IMPROVED SYNAPTIC TRANSMISSION
(FR) SUSBTANCES PHARMACEUTIQUES TENDANT A AMELIORER LA TRANSMISSION AU NIVEAU DES SYNAPSES
Abstract: front page image
(EN)Peripherally administered Brefeldin A and its analogs and derivatives are used to enhance learning and reverse memory dysfunction through induced long term potentiation in hippocampal tissues.
(FR)Brefeldine A et ses analogues et dérivés, administrés de manière périphérique pour stimuler le potentiel d'apprentissage et stopper les troubles de la mémoire grâce à une potentialisation induite à long terme dans les tissus hippocampiques.
Designated States: AU, CA, JP, KR, NO.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)